2m 2m 2m 2m 2m 2m 2m
MEREO BIOPHA SP ADS (MREO)
NASDAQ
$0.34-$0.001 (-0.41%)
Price as of Jun 03, 2026 7:59 PM EDT- $54.9MMarket Cap
- -87.19%1-Year Change
- BiotechnologyIndustry
MEREO BIOPHA SP ADS (MREO)
$0.34-$0.001 (-0.41%)
Top Holders
Institutional
Mutual Funds
Holder | Ownership %
| Shares Held | Change (Shares, %) | Report Date |
|---|---|---|---|---|
RUBRIC CAPITAL MANAGEMENT LP | 9.59% | 15.3M | 0 (0.00%) | Mar 31, 2026 |
ECOR1 CAPITAL, LLC | 8.38% | 13.4M | +5.5M (+41.23%) | Mar 31, 2026 |
683 CAPITAL MANAGEMENT, LLC | 7.52% | 12.0M | -3.0M (-25.21%) | Mar 31, 2026 |
BANK OF AMERICA CORP /DE/ | 5.13% | 8.2M | +8.2M (+99.69%) | Mar 31, 2026 |
N/A | 4.74% | 7.6M | +7.6M (+100.00%) | Mar 31, 2026 |
NEWTYN MANAGEMENT, LLC | 4.43% | 7.1M | +6.9M (+96.83%) | Mar 31, 2026 |
VIVO CAPITAL, LLC | 2.38% | 3.8M | -3.1M (-82.00%) | Mar 31, 2022 |
Holder | Ownership %
| Shares Held | Change (Shares, %) | Report Date |
|---|---|---|---|---|
Tekla World Healthcare Fund | 2.17% | 3.5M | 0 (0.00%) | Mar 31, 2026 |
TEKLA LIFE SCIENCES INVESTORS | 1.30% | 2.1M | 0 (0.00%) | Mar 31, 2026 |
FIDELITY ADVISOR SERIES VII | 0.48% | 759,100 | 0 (0.00%) | Jan 31, 2026 |
FIDELITY SELECT PORTFOLIOS | 0.20% | 320,812 | 0 (0.00%) | Feb 28, 2026 |
ETF Opportunities Trust | 0.20% | 316,197 | 0 (0.00%) | Jan 31, 2026 |
Tema ETF Trust | 0.17% | 263,453 | 0 (0.00%) | Feb 28, 2026 |
iSHARES TRUST | 0.13% | 213,432 | -148,446 (-69.55%) | Jan 31, 2026 |
Current Ownership Distribution
- Institutions1.6B (96.08%)
- Mutual Funds46.2M (2.85%)
- Insiders17.4M (1.07%)
- Other0 (0.00%)
Insider Transactions
- 1.07% (17.4M)Current InsiderOwnership (%, shares)
- 0Number of InsiderBuying (last 12 months)
- $0.00Amount of InsiderBuying (last 12 months)
- 0Number of InsiderSelling (last 12 months)
- $0.00Amount of InsiderSelling (last 12 months)
Insider Name & Title | Type | Date
| Transaction Value | Shares | Share Price | Shares After Transactions |
|---|---|---|---|---|---|---|
Jacquet Pierre | Award | Feb 26, 2026 | $0.00 | 66,000 | $0.00 | 66,000 |
Jenkins Annalisa | Award | Feb 26, 2026 | $0.00 | 66,000 | $0.00 | 66,000 |
WYZGA MICHAEL S | Award | Feb 26, 2026 | $0.00 | 66,000 | $0.00 | 66,000 |
Ekblom Anders | Award | Feb 26, 2026 | $0.00 | 66,000 | $0.00 | 66,000 |
Jacquet Pierre | Award | Feb 26, 2026 | $0.00 | 106,848 | $0.00 | 106,848 |
Jenkins Annalisa | Award | Feb 26, 2026 | $0.00 | 106,848 | $0.00 | 106,848 |
PAKIANATHAN DEEPIKA | Award | Feb 26, 2026 | $0.00 | 66,000 | $0.00 | 66,000 |
Shames Daniel | Award | Feb 26, 2026 | $0.00 | 66,000 | $0.00 | 66,000 |
Ekblom Anders | Award | Feb 26, 2026 | $0.00 | 133,560 | $0.00 | 133,560 |
Yoskowitz Marc J | Award | Feb 26, 2026 | $0.00 | 66,000 | $0.00 | 66,000 |
Shames Daniel | Award | Feb 26, 2026 | $0.00 | 96,163 | $0.00 | 96,163 |
Yoskowitz Marc J | Award | Feb 26, 2026 | $0.00 | 96,163 | $0.00 | 96,163 |
Bender Jeremy | Award | Feb 26, 2026 | $0.00 | 66,000 | $0.00 | 66,000 |
Bender Jeremy | Award | Feb 26, 2026 | $0.00 | 117,533 | $0.00 | 117,533 |
Lewicki John A. Chief Scientific Officer | Award | Feb 01, 2026 | $0.00 | 139,913 | $0.00 | 139,913 |
Fox Chrisitne Ann Chief Financial Officer | Award | Feb 01, 2026 | $0.00 | 315,750 | $0.00 | 315,750 |
Hughes-Wilson Alexandra See Remarks | Award | Feb 01, 2026 | $0.00 | 183,750 | $0.00 | 183,750 |
Scots-Knight Denise Chief Executive Officer | Award | Feb 01, 2026 | $0.00 | 1.0M | $0.00 | 1.0M |
Lewicki John A. Chief Scientific Officer | Award | Feb 01, 2026 | $0.00 | 46,637 | $0.00 | 46,637 |
Sermon Charles General Counsel | Award | Feb 01, 2026 | $0.00 | 315,750 | $0.00 | 315,750 |
Hughes-Wilson Alexandra See Remarks | Award | Feb 01, 2026 | $0.00 | 61,250 | $0.00 | 61,250 |
Scots-Knight Denise Chief Executive Officer | Award | Feb 01, 2026 | $0.00 | 345,000 | $0.00 | 345,000 |
Lewicki John A. Chief Scientific Officer | Award | Feb 01, 2026 | $0.00 | 145,000 | $0.00 | 145,000 |
Fox Chrisitne Ann Chief Financial Officer | Award | Feb 01, 2026 | $0.00 | 105,250 | $0.00 | 105,250 |
Hughes-Wilson Alexandra See Remarks | Award | Feb 01, 2026 | $0.00 | 195,000 | $0.00 | 195,000 |
Scots-Knight Denise Chief Executive Officer | Award | Feb 01, 2026 | $0.00 | 480,000 | $0.00 | 480,000 |
Sermon Charles General Counsel | Award | Feb 01, 2026 | $0.00 | 105,250 | $0.00 | 105,250 |
Fox Chrisitne Ann Chief Financial Officer | Award | Feb 01, 2026 | $0.00 | 280,000 | $0.00 | 280,000 |
Sermon Charles General Counsel | Award | Feb 01, 2026 | $0.00 | 295,000 | $0.00 | 295,000 |
Shames Daniel | Award | Feb 05, 2025 | $0.00 | 55,000 | $0.00 | 55,000 |